Double Medical(SZ:002901) Xin Lang Cai Jing·2025-09-24 03:19Group 1 - The core viewpoint of the news is that Dabo Medical has seen a stock price increase of 5.09%, reaching 55.10 CNY per share, with a total market capitalization of 22.812 billion CNY [1] - Dabo Medical specializes in the production, research, and sales of high-value medical consumables, with its main business revenue composition being: trauma products 38.68%, spinal products 17.95%, minimally invasive surgical products 16.34%, joint products 10.37%, other products 9.27%, neurosurgical products 4.50%, and dental products 2.89% [1] Group 2 - Southern Fund's Southern CSI 1000 ETF (512100) is among the top ten circulating shareholders of Dabo Medical, having increased its holdings by 141,900 shares in the second quarter, totaling 756,800 shares, which represents 0.26% of the circulating shares [2] - The Southern CSI 1000 ETF has achieved a year-to-date return of 25.67% and a one-year return of 67.42%, ranking 1948 out of 4220 and 1298 out of 3814 respectively [2] Group 3 - The fund manager of Southern CSI 1000 ETF is Cui Lei, who has been in the position for 6 years and 323 days, with a total fund asset size of 94.976 billion CNY [3] - During Cui Lei's tenure, the best fund return was 139.52%, while the worst return was -15.93% [3]